Jianghua Ran

696 total citations · 1 hit paper
30 papers, 482 citations indexed

About

Jianghua Ran is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Jianghua Ran has authored 30 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Hepatology and 12 papers in Cancer Research. Recurrent topics in Jianghua Ran's work include Liver physiology and pathology (8 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Jianghua Ran is often cited by papers focused on Liver physiology and pathology (8 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Jianghua Ran collaborates with scholars based in China and United States. Jianghua Ran's co-authors include Zongqiang Hu, Shengning Zhang, Yingpeng Zhao, Hongqiang Gao, Jie Jiang, Yanfeng Yin, Li Li, Li Wang, Yang Gao and Yang Gao and has published in prestigious journals such as PLoS ONE, Life Sciences and Molecular Cancer.

In The Last Decade

Jianghua Ran

25 papers receiving 476 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma

2023 202 citations Zongqiang Hu, Yingpeng Zhao et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jianghua Ran China	10	338	276	76	76	58	30	482
Hua Sun China	7	213 0.6×	213 0.8×	93 1.2×	84 1.1×	46 0.8×	10	401
So Hee Kang South Korea	4	333 1.0×	297 1.1×	57 0.8×	53 0.7×	30 0.5×	7	446
W-T Chen Taiwan	7	243 0.7×	215 0.8×	81 1.1×	60 0.8×	45 0.8×	12	439
Gao‐Min Liu China	9	267 0.8×	232 0.8×	78 1.0×	79 1.0×	163 2.8×	16	461
Jiongjiong Lu China	13	334 1.0×	301 1.1×	87 1.1×	102 1.3×	64 1.1×	20	498
Zongqiang Hu China	11	377 1.1×	298 1.1×	67 0.9×	53 0.7×	106 1.8×	16	514
Caixia Xia China	8	259 0.8×	219 0.8×	75 1.0×	46 0.6×	20 0.3×	12	400
Shima Mimura Japan	10	325 1.0×	173 0.6×	81 1.1×	74 1.0×	40 0.7×	41	495
Juqiang Han China	11	485 1.4×	400 1.4×	110 1.4×	72 0.9×	36 0.6×	15	668
Beicheng Sun China	11	217 0.6×	150 0.5×	112 1.5×	89 1.2×	29 0.5×	21	415

Countries citing papers authored by Jianghua Ran

Since Specialization

Citations

This map shows the geographic impact of Jianghua Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianghua Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianghua Ran more than expected).

Fields of papers citing papers by Jianghua Ran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianghua Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianghua Ran. The network helps show where Jianghua Ran may publish in the future.

Co-authorship network of co-authors of Jianghua Ran

This figure shows the co-authorship network connecting the top 25 collaborators of Jianghua Ran. A scholar is included among the top collaborators of Jianghua Ran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianghua Ran. Jianghua Ran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ran, Jianghua, et al.. (2024). Unraveling the Heterogeneity of CD8+ T-Cell Subsets in Liver Cirrhosis: Implications for Disease Progression. Gut and Liver. 19(3). 410–426. 2 indexed citations

Gao, Yang, et al.. (2024). Identification of pivotal genes and crucial pathways in liver fibrosis through WGCNA analysis. Technology and Health Care. 33(1). 431–448. 1 indexed citations

Mao, Feng, et al.. (2024). Causal role of 179 lipids in colorectal cancer: Mendelian randomization study and meta-analysis. International Journal of Surgery Global Health. 7(6).

Hu, Zongqiang, et al.. (2023). miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK. Journal of Immunology Research. 2023. 1–20. 31 indexed citations

Hu, Zongqiang, Yingpeng Zhao, Jie Jiang, et al.. (2023). Exosome‐derived miR ‐142‐5p from liver stem cells improves the progression of liver fibrosis by regulating macrophage polarization through CTSB. Environmental Toxicology. 38(8). 1860–1873. 9 indexed citations

Li, Wang, Shengning Zhang, Yingpeng Zhao, et al.. (2023). Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma. Clinical & Translational Oncology. 25(7). 2099–2115. 2 indexed citations

Zhao, Yingpeng, et al.. (2023). Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population. BMC Gastroenterology. 23(1). 260–260. 6 indexed citations

Hu, Zongqiang, et al.. (2023). MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24. Life Sciences. 325. 121773–121773. 19 indexed citations

Hu, Zongqiang, Yingpeng Zhao, Jie Jiang, et al.. (2023). Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3. Molecular Biology Reports. 50(8). 6399–6413. 22 indexed citations

10.

Hu, Zongqiang, Hongyu Zhang, Yi‐Ting Wang, et al.. (2023). Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease. Lipids in Health and Disease. 22(1). 33–33. 15 indexed citations

11.

Hu, Zongqiang, Yingpeng Zhao, Hongqiang Gao, et al.. (2023). Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Molecular Cancer. 22(1). 55–55. 202 indexed citations breakdown →

12.

Zhang, Shengning, Jiaojiao Zhao, Jianghua Ran, et al.. (2022). Characteristics of pre-sensitization-related acute antibody-mediated rejection in a rat model of orthotopic liver transplantation. Annals of Translational Medicine. 10(19). 1066–1066. 1 indexed citations

13.

Li, Wang, et al.. (2022). Integrated Bioinformatics Analysis for the Screening of Hub Genes andTherapeutic Drugs in Hepatocellular Carcinoma. Current Pharmaceutical Biotechnology. 24(8). 1035–1058. 8 indexed citations

14.

Li, Lu, Xiaokai Li, Wang Li, et al.. (2022). CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma. World Journal of Surgical Oncology. 20(1). 382–382. 1 indexed citations

15.

Zhang, Shengning, Li Li, Jianghua Ran, et al.. (2021). Long noncoding RNA NEAT1 changes exosome secretion and microRNA expression carried by exosomes in hepatocellular carcinoma cells. Journal of Gastrointestinal Oncology. 12(6). 3033–3049. 7 indexed citations

16.

Li, Li, Jianghua Ran, Shengning Zhang, et al.. (2017). Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells. OncoTargets and Therapy. Volume 10. 1003–1016. 67 indexed citations

17.

Su, Yanjun, Jianming Zhang, Jun Qian, et al.. (2015). Interferon-α2b gene-modified human bone marrow mesenchymal stem cells inhibit hepatocellular carcinoma by reducing the Notch1 levels. Life Sciences. 143. 18–26. 15 indexed citations

18.

Zhang, Shengning, et al.. (2013). Laparoscopic Cholecystectomy in Situs Inversus Totalis: a Case Report. Chinese Medical Sciences Journal. 28(4). 245–247. 3 indexed citations

19.

Zhu, Li, Juan Chen, Li Li, et al.. (2012). Human Hepatocyte Growth Factor (hHGF)-Modified Hepatic Oval Cells Improve Liver Transplant Survival. PLoS ONE. 7(9). e44805–e44805. 13 indexed citations

20.

Li, Li, Li Li, Shengning Zhang, et al.. (2011). Mechanism of Immune Hyporesponsiveness Induced by Recipient-derived Immature Dendritic Cells in Liver Transplantation Rat. Chinese Medical Sciences Journal. 26(1). 28–35. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact